Correlation Between Allakos and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Allakos and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allakos and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allakos and Blueprint Medicines Corp, you can compare the effects of market volatilities on Allakos and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allakos with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allakos and Blueprint Medicines.
Diversification Opportunities for Allakos and Blueprint Medicines
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Allakos and Blueprint is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Allakos and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Allakos is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allakos are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Allakos i.e., Allakos and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Allakos and Blueprint Medicines
Given the investment horizon of 90 days Allakos is expected to under-perform the Blueprint Medicines. In addition to that, Allakos is 2.92 times more volatile than Blueprint Medicines Corp. It trades about -0.01 of its total potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.04 per unit of volatility. If you would invest 8,099 in Blueprint Medicines Corp on September 4, 2024 and sell it today you would earn a total of 1,663 from holding Blueprint Medicines Corp or generate 20.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allakos vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Allakos |
| Blueprint Medicines Corp |
Allakos and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allakos and Blueprint Medicines
The main advantage of trading using opposite Allakos and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allakos position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Allakos vs. Apellis Pharmaceuticals | Allakos vs. Blueprint Medicines Corp | Allakos vs. Day One Biopharmaceuticals | Allakos vs. Atara Biotherapeutics |
| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |